Wednesday, July 8, 2026

Drug profile · INN

fluphenazine hydrochloride

fluphenazine hydrochloride (FLUPHENAZINE HYDROCHLORIDE) is a dopamine d2 receptor antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — fluphenazine hydrochloride
US status
approved
Class
Route
INJECTION
Patents
0
Programs
0
Data quality
0.89

Quick answer

fluphenazine hydrochloride (FLUPHENAZINE HYDROCHLORIDE) is a dopamine d2 receptor antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN fluphenazine hydrochloride
Brand FLUPHENAZINE HYDROCHLORIDE
Mechanism Dopamine D2 receptor antagonist
Target D(2) dopamine receptor
Route INJECTION
Formulation TABLET

Mechanism of action

Dopamine D2 receptor antagonist

Primary target: D(2) dopamine receptor

Approval history

Authority Status Date
FDA approved

Related & competitor drugs

  1. aripiprazole Nervous system (N05)
  2. brexpiprazole Nervous system (N05)
  3. cabergoline Dopamine D2 receptor agonist
  4. clozapine Serotonin 2a (5-HT2a) receptor antagonist
  5. fluphenazine decanoate Dopamine D2 receptor antagonist
  6. iloperidone Nervous system (N05)

Frequently asked questions

What is fluphenazine hydrochloride?

fluphenazine hydrochloride (FLUPHENAZINE HYDROCHLORIDE) is a dopamine d2 receptor antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for fluphenazine hydrochloride?

FLUPHENAZINE HYDROCHLORIDE is a marketed brand name for fluphenazine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of fluphenazine hydrochloride?

fluphenazine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.